According to DAVID, recurrent patients showed enrichment of mutated genes involved in taste reception (TAS2R30, TAS2R31, TAS2R43, and TAS2R46), while progressors showed enrichment of genes typically mutated in cancers such as endometrial, small cell lung, prostate, and breast cancer, glioma and melanoma (PIK3CA, ERBB2, PTEN, AKT1, PIK3R2, TP53, PIK3CG), and genes involved in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles (SPTA1, SPTBN5, DST, SPTAN1). This evidence concerns the gene TP53 and breast cancer.